CD38-targeted CAR-T therapy

CD38-targeted Chimeric Antigen Receptor T Cell · The First Affiliated Hospital of Soochow University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD38-targeted CAR-T therapy, covering 2020-04-24 to 2020-04-24. Get the full timeline:

Most recent: Clinical Trial Update: CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]

See pricing